| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |